Bronchoalveolar lavage fluid from patients with acute lung injury/acute respiratory distress syndrome induces myofibroblast differentiation

Critical Care Medicine

Volumn 35, Issue 3, 2007, Pages 842-848

  Synenki, Lauren ^a   Chandel, Navdeep S ^a   Budinger, G R Scott ^a   Donnelly, Helen K ^a   Topin, Jeremy ^a   Eisenbart, James ^a   Jovanovic, Borko ^a   Jain, Manu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acute respiratory distress syndrome; Alpha smooth muscle actin; Collagen 3; Repair; Transforming growth factor 1

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 3; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; INTUBATION; LUNG FIBROBLAST; LUNG LAVAGE; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ACTINS; ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; COLLAGEN TYPE III; FEMALE; FIBROBLASTS; GENE EXPRESSION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RNA, MESSENGER; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33947124743     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000257254.87984.69     Document Type: Article

References (47)

1. Jain M, Sznajder JI: Low tidal volume needs to be used in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33:239-240
2. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
3. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301-1308
4. Desai SR, Wells AU, Rubens MB, et al: Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210:29-35
5. McHugh LG, Milberg JA, Whitcomb ME, et al: Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150:90-94
6. Davidson TA, Caldwell ES, Curtis JR, et al: Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999; 281:354-360
7. Herridge MS, Cheung AM, Tansey CM, et al: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-693
8. Slutsky AS, Tremblay LN: Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998; 157:1721-1725
9. Montgomery AB, Stager MA, Carrico CJ, et al: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132:485-489
10. Nuckton TJ, Alonso JA, Kallet RH, et al: Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002; 346:1281-1286
11. Budinger GR, Chandel NS, Donnelly HK, et al: Active transforming growth factor-beta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 2005; 31:121-128
12. Clark JG, Milberg JA, Steinberg KP, et al: Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995; 122:17-23
13. Chesnutt AN, Matthay MA, Tibayan FA, et al: Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 1991; 156:840-845
14. Meduri GU, Tolley EA, Chinn A, et al: Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998; 158:1432-1441
15. Marshall RP, Bellingan G, Webb S, et al: Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000; 162:1783-1788
16. Steinberg KP, Hudson LD, Goodman RB, et al: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684
17. Sznajder I, Ridge K, Saumon G, et al: Lung injury induced by mechanical ventilation. In: Pulmonary Edema. Matthay MA, Ingbar DH (Eds). New York, Marcel Dekker, 1998, pp 413-430
18. Ingbar DH: Mechanisms of repair and remodeling following acute lung injury. Clin Chest Med 2000; 21:589-616
19. Hinz B, Gabbiani G: Cell-matrix and cell-cell contacts of myofibroblasts: Role in connective tissue remodeling. Thromb Haemost 2003; 90:993-1002
20. Phan SH: The myofibroblast in pulmonary fibrosis. Chest 2002; 122(6 Suppl):286S-289S
21. Zhang K, Flanders KC, Phan SH: Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 1995; 147:352-361
22. Grotendorst GR, Duncan MR: Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 2005; 19:729-738
23. Vaughan MB, Howard EW, Tomasek JJ: Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 2000; 257:180-189
24. Hinz B, Mastrangelo D, Iselin CE, et al: Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001; 159:1009-1020
25. Liebler JM, Qu Z, Buckner B, et al: Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax 1998; 53:823-829
26. Pache JC, Christakos PG, Gannon DE, et al: Myofibroblasts in diffuse alveolar damage of the lung. Mod Pathol 1998; 11:1064-1070
27. Horowitz JC, Cui Z, Moore TA, et al: Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2006; 290:L415-L425
28. Ware LB: Prognostic determinants of acute respiratory distress syndrome in adults: Impact on clinical trial design. Crit Care Med 2005; 33(3 Suppl):S217-s222
29. Santiago B, Gutierrez-Canas I, Dotor J, et al: Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis. J Invest Dermatol 2005; 125:450-455
30. Fahy RJ, Lichtenberger F, McKeegan CB, et al: The acute respiratory distress syndrome: A role for transforming growth factor-β1. Am J Respir Cell Mol Biol 2003; 28:499-503
31. Mori Y, Ishida W, Bhattacharyya S, et al: Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis Rheum 2004; 50:4008-4021
32. Evans RA, Tian YC, Steadman R, et al: TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 2003; 282:90-100
33. Batra V, Musani AI, Hastie AT, et al: Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004; 34:437-444
34. Meduri GU, Kohler G, Headley S, et al: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108:1303-1314
35. Bhattacharyya S, Ghosh AK, Pannu J, et al: Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta. Arthritis Rheum 2005; 52:1248-1258
36. Qiao B, Padilla SR, Benya PD: Transforming growth factor (TGF)-β-activated kinase 1 mimics and mediates TGF-β-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling 10.1074/jbc.M500646200. J Biol Chem 2005; 280:17562-17571
37. Hill JD, Ratliff JL, Parrott JC, et al: Pulmonary pathology in acute respiratory insufficiency: Lung biopsy as a diagnostic tool. J Thorac Cardiovasc Surg 1976; 71:64-71
38. Martin C, Papazian L, Payan MJ, et al: Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 1995; 107:196-200
39. Sime PJ, Xing Z, Graham FL, et al: Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100:768-776
40. Hiwatari N, Shimura S, Yamauchi K, et al: Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients. Tohoku J Exp Med 1997; 181:285-295
41. Khalil N, Greenberg AH: The role of TGF-beta in pulmonary fibrosis. Ciba Found Symp 1991; 157:194-207
42. Vittal R, Horowitz JC, Moore BB, et al: Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. Am J Pathol 2005; 166:367-375
43. McClain SA, Simon M, Jones E, et al: Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol 1996; 149:1257-1270
44. Brown RL, Ormsby I, Doetschman TC, et al: Wound healing in the transforming growth factor-b1-deficient mouse. Wound Repair Regen 1995; 3:25-36
45. Crowe MJ, Doetschman T, Greenhalgh DG: Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 2000; 115:3-11
46. Brower RG, Lanken PN, MacIntyre N, et al: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327-336
47. Perkins GD, McAuley DF, Thickett DR, et al: The beta-Agonist Lung Injury Trial (BALTI): A randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173:281-287